Literature DB >> 11422048

Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus.

M Aihara1, Y Sugita, S Takahashi, T Nagatani, S Arata, K Takeuchi, Z Ikezawa.   

Abstract

Recently, it has been proposed that viral infection is involved in the pathogenesis of hypersensitivity syndrome. Cytomegalovirus (CMV), one of the aetiological agents of infectious mononucleosis, has never been reported as an organism associated with hypersensitivity syndrome. We describe a 64-year-old man with severe phenytoin-induced hypersensitivity syndrome associated with CMV infection. Twenty-five days after the patient was started on phenytoin, he developed high fever and a generalized erythematous rash followed by jaundice, renal failure and disseminated intravascular coagulopathy (DIC). CMV-specific IgG antibodies were significantly increased 7 weeks after the onset of clinical symptoms and the increase was associated with the appearance of CMV-specific IgM. CMV DNA was detected in the serum of the patient. Coinfection with other viruses, such as Epstein-Barr virus and human herpesviruses 6 and 7, could be excluded because antibody titres to those viruses did not increase during the clinical course of his illness. We suggest that reactivation of CMV may contribute, at least in some cases, to the development of hypersensitivity syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422048     DOI: 10.1046/j.1365-2133.2001.04239.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

2.  Isolated ileal perforation due to cytomegalovirus reactivation during management of terbinafine hypersensitivity.

Authors:  Soichi Sano; Hiroki Ueno; Keiko Yamagami; Yosuke Yakushiji; Yoshihiro Isaka; Isao Kawasaki; Masashi Takemura; Takeshi Inoue; Masayuki Hosoi
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

Review 3.  Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

Authors:  Ivan Gentile; Maria Talamo; Guglielmo Borgia
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

Review 4.  Occupational trichloroethylene exposure as a cause of idiosyncratic generalized skin disorders and accompanying hepatitis similar to drug hypersensitivities.

Authors:  Michihiro Kamijima; Naomi Hisanaga; Hailan Wang; Tamie Nakajima
Journal:  Int Arch Occup Environ Health       Date:  2006-11-15       Impact factor: 2.851

Review 5.  Antiepileptic hypersensitivity syndrome: clinicians beware and be aware.

Authors:  Olga Bessmertny; Trinh Pham
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

Review 6.  Severe drug eruptions revisited.

Authors:  Sebastien Calbo
Journal:  Immunol Res       Date:  2012-09       Impact factor: 4.505

Review 7.  Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).

Authors:  Fumi Miyagawa; Hideo Asada
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

Review 8.  A complex interaction between drug allergy and viral infection.

Authors:  Tetsuo Shiohara; Yoko Kano
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

9.  Anticonvulsant hypersensitivity syndrome associated with Epstein-Barr virus reactivation.

Authors:  Jae Yong Chang; Soo-Chan Kim
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.